Dosidal · Switzerland

Daunoblastin, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68340 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68340
atc: L01DB02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2021-11-04
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01DB02
authorisation_number: 68340
form: PULPI
holder: Pfizer AG
holder_partner_nr: 1001107
it_number: 07.16.1.
name: Daunoblastin, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
E778zmQNET1KQt9fWTbclpNFmcHoQ3KS0CdDOTBVDEZPULLtj3gCUNkwMhviiLbCoS-JESAy_HmWMer9y4JRHw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68340 · Same medicine in other markets · Dosidal